Rates of complete somatic symptom resolution among depressed patients treated with venlafaxine or SSRIS

被引：0
|
作者：
Entsuah, R
机构：
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S181 / S181
页数：1
相关论文
共 50 条
  • [41] Dynamic time warp analysis of individual symptom trajectories in depressed patients treated with electroconvulsive therapy
    Booij, Marijke M.
    van Noorden, Martijn S.
    van Vliet, Irene M.
    Ottenheim, Nathaly Rius
    van der Wee, Nic J. A.
    Van Hemert, A. M.
    Giltay, Erik J.
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 293 : 435 - 443
  • [42] MADRS Symptom Subtypes in ECT-Treated Depressed Patients Relationship to Response and Subsequent ECT
    Spashett, Renee
    Fernie, Gordon
    Reid, Ian C.
    Cameron, Isobel M.
    JOURNAL OF ECT, 2014, 30 (03) : 227 - 231
  • [43] Cognitive function and depression in symptom resolution in schizophrenia patients treated with an atypical antipsychotic
    Stip, E
    Mancini-Marïe, A
    BRAIN AND COGNITION, 2004, 55 (03) : 463 - 465
  • [44] Clinical relevance of depressive symptom improvement in bipolar depressed patients treated with olanzapine-fluoxetine combination
    Williamson, DJ
    Brown, EB
    Perlis, RH
    Toalson, P
    Ahl, J
    BIPOLAR DISORDERS, 2005, 7 : 112 - 112
  • [45] Clinical relevance of depressive symptom improvement in bipolar depressed patients treated with olanzapine-fluoxetine combination
    Williamson, D
    Brown, E
    Perlis, R
    Ahl, J
    Tollefson, G
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S216 - S216
  • [46] A comparison of venlafaxine 37.5 mg twice a day with fluoxetine 20 mg once a day in depressed patients treated in general practice
    Tylee, A
    Bowden, M
    Reynolds, A
    PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 528 - 528
  • [47] Genotypic and phenotypic CYP2D6 poor metaboliser status in depressed patients treated with venlafaxine extended release
    Kane, C.
    Nichols, A.
    Chhaya, V.
    Buckley, G.
    Guico-Pabia, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S385 - S386
  • [48] Remission with mirtazapine versus SSRIs: A meta-analysis on data of more than 2500 depressed patients treated in randomized controlled trials
    Thase, ME
    Schutte, AJ
    van der Flier, S
    Heukels, AJ
    JOURNAL OF AFFECTIVE DISORDERS, 2004, 78 : S136 - S136
  • [49] The effect of somatic symptom attribution on the prevalence rate of depression and anxiety among nursing home patients
    Smalbrugge, M
    Pot, AM
    Jongenelis, L
    Beekman, ATF
    Eefsting, JA
    INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH, 2005, 14 (03) : 146 - 150
  • [50] Risk factors for symptom exacerbation among treated patients with substance use disorders
    Moos, RH
    Nichol, AC
    Moos, BS
    ADDICTION, 2002, 97 (01) : 75 - 85
12345